Edition:
United Kingdom

Solasia Pharma KK (4597.T)

4597.T on Tokyo Stock Exchange

225JPY
5:00am BST
Change (% chg)

¥-1 (-0.44%)
Prev Close
¥226
Open
¥224
Day's High
¥225
Day's Low
¥222
Volume
460,500
Avg. Vol
1,872,498
52-wk High
¥476
52-wk Low
¥210

Latest Key Developments (Source: Significant Developments)

Solasia Pharma to issue new shares to raise up to 4.34 bln yen
Tuesday, 28 Aug 2018 

Aug 28 (Reuters) - Solasia Pharma KK <4597.T>:Says it will issue 14.8 million shares via public offering and 2.2 million shares via private placement .Says it aims to raise up to 4.34 billion yen in total, to invest in clinical trials .  Full Article

Solasia Pharma says termination of clinical trials phase 1 of SP-04
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Solasia Pharma KK <4597.T>:Says it announces termination of SP-04 clinical trials phase 1, for treatment of peripheral nerves disability .  Full Article

Pledpharma and Solasia enter license agreement on Pledox in Asia
Monday, 20 Nov 2017 

Nov 20 (Reuters) - PLEDPHARMA AB (PUBL) :PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA .PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY UPFRONT, DEVELOPMENT, REGULATORY AND SALES MILESTONES OF UP TO ABOUT USD 83 MILLION​.PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY INDUSTRY STANDARD ROYALTY RATES ON SALES​.PLEDPHARMA AB (PUBL) - ‍WILL ALSO FULLY FINANCE AN EXPANSION OF PHASE III PROGRAM FOR PLEDOX​.‍TOTAL VALUE OF UPFRONT AND MILESTONE PAYMENTS IS UP TO JPY 9.3 BILLION​.‍PHASE III STUDIES ANTICIPATED TO BE INITIATED END OF 2017 WITH TOP LINE RESULTS EXPECTED IN 2020​.  Full Article

Solasia Pharma to sign distributorship agreement with ITOCHU
Wednesday, 13 Sep 2017 

Sept 13(Reuters) - Solasia Pharma KK <4597.T>:Says it plans to sign a distributorship agreement with ITOCHU Corp <<<8001.T>>>, regarding sales of the company's products in China (except Hong Kong and Macau ).  Full Article

Solasia Pharma announces approval of episil® oral liquid in Japan
Friday, 7 Jul 2017 

July 7(Reuters) - Solasia Pharma KK <4597.T>:Says it obtained the marketing approval of episil®(SP-03), in Japan, on July 6.  Full Article

JapanBridge (Ireland) cuts voting power in Solasia Pharma KK to 19.7 pct
Thursday, 29 Jun 2017 

June 29(Reuters) - Solasia Pharma KK <4597.T>:Says JapanBridge (Ireland) Limited cut voting power in the company to 19.7 percent from 24 percent.Effective June 22.  Full Article

JapanBridge (Ireland) to cut voting power in Solasia Pharma KK to 7.9 pct
Wednesday, 28 Jun 2017 

June 28(Reuters) - Solasia Pharma KK <4597.T>:Says its second biggest shareholder JapanBridge (Ireland) Limited will cut voting power in the company to 7.9 percent from 24 percent.Effective date will be on July 3.  Full Article

Solasia Pharma to raise 496.2 mln yen in shares private placement
Thursday, 20 Apr 2017 

April 20 (Reuters) - Solasia Pharma KK <4597.T> ::* Says the co to issue new shares via private placement and raise 496.2 million yen, with subscription date on April 24 and payment date on April 25.  Full Article

Solasia Pharma says listing on TSE Mothers
Friday, 24 Mar 2017 

Solasia Pharma KK <4597.T> :Says its stock began listing on Tokyo Stock Exchange (TSE) Mothers on March 24.  Full Article

Solasia Pharma KK announces IPO on TSE Mothers on March 24
Wednesday, 22 Mar 2017 

Solasia Pharma KK <4597.T>: Says its stock will begin trading on the Tokyo Stock Exchange (TSE) Mothers on March 24, 2017, under the symbol "4597" . The company will offer a total of 19,437,500 shares . Says the nominal offering price as of filing date of Registration Statement is 180 yen per share with total offering amount will be 3.5 billion yen, and the fixed offering price will be announced at later date .Mizuho Securities Co Ltd, Mitsubishi UFJ Morgan Stanley Securities Co Ltd and SMBC Nikko Securities Inc included, 12 securities companies will be the underwriters for this offer.  Full Article